Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 220S220 trades$52.89M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
MSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
FFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
MGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 900.0K sh | Apr 8, 2026 |
| 0 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 16.7K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Derivative conversion · 10b5-1 plan | C | — 5,000 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $107K 14.7K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Apr 8, 2026 traded Apr 8, 2026 |
| 0 | Feuardent Moreira AndreasChief Innovation Officer |  LAESSEALSQ CorpOption exercise · 10b5-1 plan | M | — 10.0K sh | Apr 8, 2026 traded Apr 7, 2026 |
| 0 | Feuardent Moreira AndreasChief Innovation Officer | LAESSEALSQ Corp Option exercise · 10b5-1 plan | M | $100 10.0K sh | Apr 8, 2026 traded Apr 7, 2026 |
| 0 |  Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | NETCloudflare, Inc. Derivative conversion · 10b5-1 plan | C | — 52.4K sh | Apr 8, 2026 traded Apr 7, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 14.7K sh | Apr 8, 2026 traded Apr 7, 2026 |
| 0 | Date Rajeev VDirector | CRCLCircle Internet Group, Inc. Option exercise · 10b5-1 plan | M | — 1,273 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 0 | Moat RossCHIEF OPERATING OFFICER |  KNSAKiniksa Pharmaceuticals International, plcTax withholding · 10b5-1 plan | F | $38K 774 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 0 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Option exercise · 10b5-1 plan | M | — 5,000 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 900.0K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Gibson ChristopherDirector |  RXRXRECURSION PHARMACEUTICALS, INC.Derivative conversion · 10b5-1 plan | C | — 40.0K sh | Apr 8, 2026 traded Apr 7, 2026 |
| 0 | Date Rajeev VDirector | CRCLCircle Internet Group, Inc. Option exercise · 10b5-1 plan | M | — 2,546 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 6,250 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Desmond SeanDirector, CEO & President |  NCNOnCino, Inc.Option exercise · 10b5-1 plan | M | $40K 8,065 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 225.0K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Option exercise · 10b5-1 plan | M | — 5,000 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 0 | Cannestra AnthonyDirector |  BZAIBlaize Holdings, Inc.Option exercise · 10b5-1 plan | M | $28K 50.0K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Derivative conversion · 10b5-1 plan | C | — 5,000 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 0 | Date Rajeev VDirector | CRCLCircle Internet Group, Inc. Option exercise · 10b5-1 plan | M | $204 2,546 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Cowan ElviaSVP, Finance & CAO |  PCVXVaxcyte, Inc.Option exercise · 10b5-1 plan | M | — 3,000 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 0 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | NETCloudflare, Inc. Derivative conversion · 10b5-1 plan | C | — 52.4K sh | Apr 8, 2026 traded Apr 7, 2026 |
| 0 |  Tenev VladimirDirector, Chief Executive Officer | HOODRobinhood Markets, Inc. Derivative conversion · 10b5-1 plan | C | — 375.0K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Moat RossCHIEF OPERATING OFFICER | KNSAKiniksa Pharmaceuticals International, plc Option exercise · 10b5-1 plan | M | — 2,477 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Apr 8, 2026 traded Apr 8, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $107K 14.7K sh | Apr 8, 2026 traded Apr 8, 2026 |
| 0 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | NETCloudflare, Inc. Derivative conversion · 10b5-1 plan | C | — 52.4K sh | Apr 8, 2026 traded Apr 8, 2026 |
| 0 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 16.7K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Desmond SeanDirector, CEO & President | NCNOnCino, Inc. Option exercise · 10b5-1 plan | M | — 8,065 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Doyle MittieChief Medical Officer |  AVTXAvalo Therapeutics, Inc.Option exercise · 10b5-1 plan | M | — 3,970 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 16.7K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 50 | Thompson Amanda JChief People Officer |  GAPGAP INCOpen-market sale | SELL | $583K 23.2K sh | Apr 7, 2026 traded Apr 6, 2026 |
| 49 | Warrick TimothyPortfolio Manager | NAPrincipal Private Credit Fund Open-market purchase | BUY | $144K 14.1K sh | Apr 7, 2026 traded Apr 6, 2026 |
| 45 | Rowley RussellInvestment Committee | NAPrincipal Private Credit Fund Open-market purchase | BUY | $57K 5,608 sh | Apr 7, 2026 traded Apr 6, 2026 |
| 43 | Bron OlivierCEO, Bloomingdale's |  MMacy's, Inc.Open-market sale | SELL | $130K 7,228 sh | Apr 7, 2026 traded Apr 6, 2026 |
| 39 | Preston Tracy MEVP, CLO & Corporate Secretary | MMacy's, Inc. Open-market sale | SELL | $94K 5,271 sh | Apr 7, 2026 traded Apr 6, 2026 |
| 36 | Thompson Amanda JChief People Officer | GAPGAP INC Open-market sale | SELL | $45K 1,788 sh | Apr 7, 2026 traded Apr 6, 2026 |
| 35 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER |  ACADACADIA PHARMACEUTICALS INCOpen-market sale | SELL | $60K 2,709 sh | Apr 7, 2026 traded Apr 7, 2026 |